About Us
About OnCusp
Culture and Values
Company Milestones
Management Team
Board of Directors
Scientific Advisory Board
R&D
Strategy
Pipeline
Expanded Access Policy
Partnership
Business Development Approach
Our Top Investors
Newsroom
Company News
Coverage
Publications
Careers
Careers
Join Our Team
Job Opportunities
Contact
CN
For Chinese biotechs, the out-licensing business is scorching hot. Could geopolitics rain on their parade?
Apr 11, 2024
Prev article :OnCusp: Bing Yuan’s newco to provide bridge from innovation to MNC（by BioCentury）
Back
